Amyloid plaques themselves function as endogenous TLR4 agonists, creating a fundamentally different baseline inflammatory state in the AD brain that transforms how chronic fentanyl exposure is interpreted by the microglial compartment. The gene discussed is TLR4; the disease is Alzheimer disease.